Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3
Toni M. Brand(University of Wisconsin–Madison), Deric L. Wheeler(University of Wisconsin–Madison)
Cited by 27
Related Papers
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
|Molecular Cancer|2014|64
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer
|BMC Cancer|2022|16
AXL Regulates Neuregulin1 Expression Leading to Cetuximab Resistance in Head and Neck Cancer
|Research Square|2021|1